about
A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of MelasmaInterventions for melasmaHeterogeneous Pathology of Melasma and Its Clinical ImplicationsCritical review of Ayurvedic Varṇya herbs and their tyrosinase inhibition effectBrazilian consensus on photoprotectionMicrowave-assisted synthesis and tyrosinase inhibitory activity of chalcone derivatives[Melasma : An update on the clinical picture, treatment, and prevention].Measuring melasma patients' quality of life using willingness to pay and time trade-off methods in Thai population.Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports.Melasma: treatment evaluation.Acne in skin of color: practical approaches to treatment.Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: a prospective study.Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma.Topical treatment of melasma.A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis.Successful treatment of malar dermal melasma with a fractional ablative CO₂ laser in a patient with type V skin.Split-face study of melasma patients treated with non-ablative fractionated photothermolysis (1540 nm).Better clinical results with long term benefits in melasma patients.Melasma: treatment strategy.Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser.Melasma: a clinical and epidemiological reviewSuccessful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.Split-face comparative study of 1550 nm fractional photothermolysis and trichloroacetic acid 15% chemical peeling for facial melasma in Asian skin.Melasma in men.Intense Pulsed Light and Low-Fluence Q-Switched Nd:YAG Laser Treatment in Melasma PatientsAcne in patients with skin of color: practical management.Treatment of melasma by low-fluence 1064 nm Q-switched Nd:YAG laser.Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial.Treatment of melasma with the 1,927-nm fractional thulium fiber laser: a retrospective analysis of 20 cases with long-term follow-up.Topical tranexamic acid as a promising treatment for melasmaTranexamic acid in treatment of melasma: A comprehensive review of clinical studies.MITF-siRNA formulation is a safe and effective therapy for human melasmaThe efficacy in melasma treatment using a 1410 nm fractional photothermolysis laser.Treatment of infraorbital dark circles in atopic dermatitis with a 2790-nm erbium: yttrium scandium gallium garnet laser: a pilot study.The use of ablative lasers in the treatment of facial melasma.A new concept in the topical treatment of onychomycosis with cyanoacrylate, undecylenic acid, and hydroquinone.The dual toning technique for melasma treatment with the 1064 nm Nd: YAG laser: A preliminary study.A study on fractional erbium glass laser therapy versus chemical peeling for the treatment of melasma in female patientsTreatment of refractory melasma with combination of topical 5% magnesium ascorbyl phosphate and fluorescent pulsed light in Asian patients.A comparative study of low-fluence 1,064 nm Q-Switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients.
P2860
Q21296792-31E283C6-7E6A-43A5-BC77-A798099B2D09Q24234094-23D3F8AF-510A-4A8D-940B-C97103FBFB08Q26744829-25A461BA-3031-469C-BC7D-1489196DE1A0Q26776312-608A04B6-4C3C-4811-88C3-9BF5A3DFE352Q26825276-1589B9D3-4083-46C9-BB17-AB2DEE927AA5Q28286642-5F9197CD-A631-4DB6-81FB-B7519C7BFCA2Q30239038-BD9E5CA1-7FF5-4C58-92EE-9C1567A175F3Q31043661-28E81307-1D72-45AD-9211-2C17166E9C56Q33369116-F86A3634-0CE4-412A-B6D1-81FECC58CEB9Q33425959-BD91E8C9-E284-459B-B229-CB97B356EF94Q33529462-5E7F55C2-FD1C-46EC-8B5B-27EBC58740DFQ33580943-278B5954-96CF-4366-9E89-A8C7CD7AECC5Q33590057-4E3B09F1-9919-45C6-B383-DC2BA29C0B25Q33595442-8C55DFA4-D5C3-485D-BC76-2FE4B01B24A9Q33715243-609C020F-0EA3-4052-AE7F-B22B82EC6444Q33766251-73429499-6FED-4B75-8BC3-6AAAB0DDE789Q33882275-BFF65BCB-7624-46B4-B692-B67E5DFF5222Q33975382-FD3DE720-0DD6-460F-B099-8B6F5303455EQ34043685-DF8927D1-1B9E-4EE1-84B5-ECE579424CDEQ34079532-796C31CE-DBF3-4A64-95B5-A852948CD3ABQ34140514-C757D3BB-E682-4278-8022-2FED6AD77CD9Q34158946-59C79B5F-EA89-48D1-AC5C-A3C6F5FDF2B4Q34174798-AE34645E-5AA3-4AF4-AF83-EEE3DFF15E6DQ34294220-29EF37A2-E43D-459E-9696-FD49869DC2F9Q34373718-998DAB14-921F-4C0B-81CF-555BDE800444Q34382519-4D748828-3D09-461F-9796-F7C0014B83EBQ34431815-4496AB4D-7DE3-401D-91A1-62B8B3FA1E6EQ34440249-D1B3B747-EC12-498A-B32A-9A385904E7D1Q34518667-B89BFF02-D15C-4CD7-80E0-0AE2AFB7A0CFQ34529832-5B207E9D-DB1A-4762-95BD-CF97D13BF3ADQ34550230-2CA218DE-228E-408A-9452-0ADF02198DCBQ34556920-21401839-DFCC-4F82-81C0-2978E6751CEFQ34561023-11798C6E-5F30-41B7-AC7D-7622B087F25EQ34610166-6EF2381C-371C-4715-BD20-FE5D128E5C88Q34759950-9108AE7C-977D-4076-BFA2-C6D02E1CCC0FQ35007760-3119C028-0100-4801-A6FA-ED40AA8469F1Q35025036-C55F4583-2F8D-4342-895A-A06DC5D5D309Q35026969-53C1BD38-B5AB-41A8-8227-02822A4CE359Q35028160-E5512A34-97A8-4823-8976-C64378DBC61EQ35045791-1D09CF20-31E1-4E5D-B524-35AA876431DD
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The treatment of melasma: a review of clinical trials.
@ast
The treatment of melasma: a review of clinical trials.
@en
type
label
The treatment of melasma: a review of clinical trials.
@ast
The treatment of melasma: a review of clinical trials.
@en
prefLabel
The treatment of melasma: a review of clinical trials.
@ast
The treatment of melasma: a review of clinical trials.
@en
P2093
P1476
The treatment of melasma: a review of clinical trials.
@en
P2093
Keyvan Nouri
Melissa D Gover
Susan Taylor
P304
P356
10.1016/J.JAAD.2006.02.009
P407
P577
2006-09-28T00:00:00Z